Skip to content
THE ELONOMISThomeFree brief

Neuralink

News

Neuralink’s PRIME2 study adds chronic ischemic stroke

Up to 10 participants at up to five sites. The University of Miami is recruiting. ALS and spinal cord injury remain in the study.

The Elonomist desk

Published
Updated

Last verified

Report an error

PRIME2, a new US early feasibility study of the N1 implant, adds chronic ischemic stroke to ALS and spinal cord injury. The study lists up to 10 participants at up to five sites. The University of Miami is recruiting.

Sources

  1. 1